Pfizer: A Strong Buy Trading Below A 10 P/E Ratio

JHVEPhotoPfizer's (NYSE:PFE) stock has cratered following the end of its freefall profits from COVID-related vaccine sales. In fact, Pfizer's stock is down by nearly 55% from its ATH in late 2021 and roughly 50% below its high in late 2022. Pfizer's market cap melted from over $$330 billion to around $$150 billion, approximately a 13-year low. Market cap (companiesmarketcap.com )However, despite Pfizer's post-COVID-19 melt-up and subsequent meltdown, it remains a solid market-leading company with consider ...